Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Genentech presents Avastin glioblastoma data

DNA presented data from a Phase II trial to treat glioblastoma that showed Avastin bevacizumab

Read the full 152 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE